全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

CBD: A New Hope?

DOI: https://doi.org/10.1021/acsmedchemlett.9b00127

Full-Text   Cite this paper   Add to My Lib

Abstract:

High Resolution Image Download MS PowerPoint Slide The nonpsychoactive phytocannabinoid, CBD, was recently approved by the Food and Drug Administration for the treatment of children with drug-resistant epilepsy. This milestone opens new avenues for cannabinoid research. In this Viewpoint, we provide an overview of recent progress in the field highlighting molecular insights into CBD’s mechanism of action, as well as its therapeutic potential

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133